Shares of Kiniksa Pharmaceuticals International, plc (KNSA) have gained 15% over the past four weeks to close the last trading session at $33.38, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$42.29 indicates a potential upside of 26.7%. While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issue ...